Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


An analysis of the latest medical device reporting (MDR) requirements for manufacturers by Jonathan Kahan

This article was originally published in Clinica

Executive Summary

The US FDA's final rule revising the medical device reporting (MDR) requirements is due to come into effect on July 31st, 1996. The final revisions to the MDR regulation are unusual in several respects. First, in an era of congressional criticism of burdensome FDA regulations, the new MDR requirements impose several new extremely burdensome and costly requirements on industry.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts